Bolt Biotherapeutics, Inc. (BOLT)
NASDAQ: BOLT · Real-Time Price · USD
4.570
-0.130 (-2.77%)
At close: Nov 14, 2025, 4:00 PM EST
4.523
-0.048 (-1.04%)
After-hours: Nov 14, 2025, 5:51 PM EST
Bolt Biotherapeutics Market Cap
Bolt Biotherapeutics has a market cap or net worth of $8.77 million as of November 14, 2025. Its market cap has decreased by -64.44% in one year.
Market Cap
8.77M
Enterprise Value
-1.81M
1-Year Change
-64.44%
Ranking
Category
Stock Price
$4.57
Market Cap Chart
Since the IPO on February 5, 2021, Bolt Biotherapeutics's market cap has decreased from $690.43M to $8.77M, a decrease of -98.73%. That is a compound annual growth rate of -59.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 14, 2025 | 8.77M | -57.17% |
| Dec 31, 2024 | 20.48M | -51.84% |
| Dec 29, 2023 | 42.52M | -13.15% |
| Dec 30, 2022 | 48.96M | -73.20% |
| Dec 31, 2021 | 182.69M | -73.54% |
| Feb 5, 2021 | 690.43M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 918.02B |
| Johnson & Johnson | 472.05B |
| AbbVie | 410.67B |
| UnitedHealth Group | 291.55B |
| AstraZeneca | 276.16B |
| Novartis AG | 252.58B |
| Merck & Co. | 230.63B |
| Abbott Laboratories | 227.08B |